🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
92.49
+0.54 (0.59%)
At close: Nov 18, 2026, 4:00 PM EST
92.60
+0.11 (0.12%)
After-hours: Nov 18, 2026, 4:32 PM EST

Mirum Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
243.19296.68222.5286.332831.34
Short-Term Investments
130.586.6457.81-123.72125.2
Cash & Short-Term Investments
373.69383.33280.32286.33151.72156.54
Cash Growth
-0.50%36.75%-2.10%88.72%-3.08%-32.47%
Accounts Receivable
156.35123.3378.2967.9723.993.27
Other Receivables
-----0.3
Receivables
156.35123.3378.2967.9723.993.57
Inventory
25.4924.8922.422.315.571.51
Prepaid Expenses
31.1118.1411.7810.948.954.97
Total Current Assets
586.63549.68392.79387.54190.23166.59
Property, Plant & Equipment
14.6110.69.811.992.352.55
Long-Term Investments
126.778.1112.53--4.98
Other Intangible Assets
275.65260.92249.82252.9358.9518.74
Other Long-Term Assets
22.9613.55.814.17101.38101.79
Total Assets
1,027842.81670.75646.62352.91294.65

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
13.659.6114.627.428.699.17
Accrued Expenses
170.88105.5670.9754.8934.7324.42
Current Portion of Leases
2.62.141.711.10.930.71
Other Current Liabilities
95.9688.4839.2623.6520.378.3
Total Current Liabilities
283.08205.8126.5587.0664.7342.6
Long-Term Debt
731.25309.8308.08306.42--
Long-Term Leases
9.727.527.970.621.261.9
Other Long-Term Liabilities
56.755.012.513.85144.88129.94
Total Liabilities
1,081528.12445.11397.95210.87174.44

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.0100
Additional Paid-In Capital
1,514981.88870.19803.26535.07377.4
Retained Earnings
-1,566-667.54-644.18-556.24-392.82-257.16
Comprehensive Income & Other
-2.060.35-0.371.64-0.22-0.04
Total Common Equity
-54.19314.69225.64248.67142.04120.21
Shareholders' Equity
-54.19314.69225.64248.67142.04120.21
Total Liabilities & Equity
1,027842.81670.75646.62352.91294.65

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
743.56319.45317.76308.142.192.61
Net Cash (Debt)
-369.8863.88-37.45-21.82149.53153.93
Net Cash Growth
-----2.86%-32.65%
Net Cash Per Share
-6.181.27-0.79-0.534.405.08
Filing Date Shares Outstanding
65.2860.3449.014737.9531.73
Total Common Shares Outstanding
65.2151.948.3446.7236.9630.58
Working Capital
303.55343.89266.24300.48125.5124
Book Value Per Share
-0.836.064.675.323.843.93
Tangible Book Value
-329.8453.77-24.18-4.2683.08101.47
Tangible Book Value Per Share
-5.061.04-0.50-0.092.253.32
Machinery
-2.161.640.910.60.2
Leasehold Improvements
-0.80.21.31.311.48
SEC Filings: 10-K · 10-Q